Literature DB >> 7722345

Accuracy and precision of quantitative arteriography in the evaluation of coronary artery disease after coronary bypass surgery. A validation study.

M Syvänne1, M S Nieminen, M H Frick.   

Abstract

Computer-assisted quantitative coronary arteriography (QCA) has gained widespread acceptance in assessing changes in coronary dimensions over time, but little is known about the utility of QCA in patients having undergone coronary bypass surgery. As a validation study, we analyzed the accuracy and precision of QCA in a subset of the baseline angiograms of a clinical trial in 395 post-bypass men with low HDL cholesterol concentrations who have been randomized to receive double-blind gemfibrozil or placebo for 2 1/2 years. Based on repeat measurements of the same cineframe, the average diameter of a segment (ADS) had a mean coefficient of variation (CV) of 3.1%. The mean CVs of the minimum luminal diameter (MLD), percent diameter stenosis (PDS) and stenotic flow reserve of an obstruction were 8.6, 10.2 and 9.8%, respectively, but the area of the atherosclerotic plaque had an unacceptably high CV, 24.0%. When the measurements from two contrast injections into a native coronary artery during the same angiographic session were compared, precision (standard deviation of the differences) was 0.198 mm for ADS, 0.192 mm for MLD, and 7.37% for PDS. Variability was not substantially reduced when measurements from 3 or 5 consecutive cineframes were averaged. Comparable repeatability was found when venous bypass grafts were imaged twice, whether the grafts themselves or the grafted native vessels were analyzed. We conclude that QCA has an acceptable accuracy and precision in analyzing coronary dimensions in bypass-grafted patients. A change of 0.40 mm in ADS and MLD, and 20% in PDS represent true progression or regression of coronary atherosclerosis with more than 95% confidence.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7722345     DOI: 10.1007/bf01137715

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  23 in total

Review 1.  Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis. Value, limitations, and implications for clinical trials.

Authors:  P J de Feyter; P W Serruys; M J Davies; P Richardson; J Lubsen; M F Oliver
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

2.  Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials.

Authors:  C M Gibson; T Sandor; P H Stone; R C Pasternak; B Rosner; F M Sacks
Journal:  Am J Cardiol       Date:  1992-05-15       Impact factor: 2.778

3.  Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.

Authors:  J H Reiber; P W Serruys; C J Kooijman; W Wijns; C J Slager; J J Gerbrands; J C Schuurbiers; A den Boer; P G Hugenholtz
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

4.  Progression of coronary artery disease in randomized medical and surgical patients over a 5-year angiographic follow-up.

Authors:  M H Frick; M Valle; P T Harjola
Journal:  Am J Cardiol       Date:  1983-10-01       Impact factor: 2.778

5.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

Authors:  G Brown; J J Albers; L D Fisher; S M Schaefer; J T Lin; C Kaplan; X Q Zhao; B D Bisson; V F Fitzpatrick; H T Dodge
Journal:  N Engl J Med       Date:  1990-11-08       Impact factor: 91.245

6.  Assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VII. Validation of coronary flow reserve as a single integrated functional measure of stenosis severity reflecting all its geometric dimensions.

Authors:  R L Kirkeeide; K L Gould; L Parsel
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

7.  Precision and reproducibility of quantitative coronary angiography with applications to controlled clinical trials. A sampling study.

Authors:  R H Selzer; C Hagerty; S P Azen; M Siebes; P Lee; A Shircore; D H Blankenhorn
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

8.  Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.

Authors:  P R Lichtlen; P G Hugenholtz; W Rafflenbeul; H Hecker; S Jost; J W Deckers
Journal:  Lancet       Date:  1990-05-12       Impact factor: 79.321

9.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.

Authors:  D Ornish; S E Brown; L W Scherwitz; J H Billings; W T Armstrong; T A Ports; S M McLanahan; R L Kirkeeide; R J Brand; K L Gould
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

View more
  4 in total

1.  Validation of an accurate method for three-dimensional reconstruction and quantitative assessment of volumes, lengths and diameters of coronary vascular branches and segments from biplane angiographic projections.

Authors:  E Wellnhofer; A Wahle; I Mugaragu; J Gross; H Oswald; E Fleck
Journal:  Int J Card Imaging       Date:  1999-10

2.  Validation of coronary artery saphenous vein bypass graft diameter measurements using quantitative angiography.

Authors:  J Lespérance; L Campeau; J H Reiber; M Bois; I Dyrda; J Laurier; G Hudon
Journal:  Int J Card Imaging       Date:  1996-12

3.  Issues of multiple frame averaging in quantitative coronary arteriography.

Authors:  J H Reiber
Journal:  Int J Card Imaging       Date:  1994-12

4.  Heart rate variability associates with asymptomatic coronary atherosclerosis.

Authors:  Sakari Simula; Esko Vanninen; Seppo Lehto; Antti Hedman; Pia Pajunen; Mikko Syvänne; Juha Hartikainen
Journal:  Clin Auton Res       Date:  2013-11-30       Impact factor: 4.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.